TABLE 1.
Digital technologies | Operational details | Estimate of effect | |
Active TB# | LTBI | ||
MM: Wisepill |
|
Assumed effect was equivalent to DOT/standard of care | Assumed effect was equivalent to that of MM in trials of active TB¶ |
MM: 99DOTS |
|
Assumed effect was equivalent to DOT/standard of care | Assumed effect was equivalent to that of MM in trials of active TB¶ |
VOT |
|
Assumed effect was equivalent to DOT/standard of care | Assumed effect was equivalent to that of MM in trials of active TB¶ |
Two-way SMS |
|
Not estimated | Assumed effect was equivalent to that of two-way SMS in trials of HIV+ |
MM: medication monitor; VOT: video-observed therapy; SMS: short message service; HCW: healthcare worker; DOT: directly observed treatment. #: routine in-person DOT visits were replaced by digital technologies for active TB treatment supervision; ¶: patients using digital interventions were 1.18 (95% CI 1.08–1.26) times more likely to complete treatment than those on self-administered treatment (derived from [33]); +: patients using digital intervention were 1.24 (95% CI 1.06–1.45) times more likely to complete treatment than those on self-administered treatment [34].